Filter
1388
Text search:
country
readiness
Featured
Recommendations
140
New Publications
373
Language
Document type
No document type
685
Studies & Reports
225
Guidelines
199
Strategic & Response Plan
107
Manuals
87
Fact sheets
29
Situation Updates
24
Training Material
17
Resource Platforms
11
Online Courses
3
Brochures
1
Countries / Regions
India
60
Global
60
Kenya
49
Sierra Leone
36
Ethiopia
32
Tanzania
32
Nepal
29
Liberia
28
Nigeria
28
Syria
26
Myanmar / Burma
24
Congo, Democratic Republic of
23
Rwanda
23
Bangladesh
23
Malawi
23
Uganda
22
Africa
22
Zambia
21
Western and Central Europe
21
Ghana
20
South Africa
20
Ukraine
18
South Sudan
15
East and Southern Africa
14
West and Central Africa
14
Philippines
13
South–East Asia Region
13
Senegal
12
Russia
12
Mozambique
11
Middle East and North Africa
11
Zimbabwe
9
Namibia
9
Pakistan
8
Afghanistan
8
Indonesia
8
Eswatini/ Swaziland
8
Latin America and the Carribbean
8
Eastern Europe
8
Brazil
7
Eastern Europe and Central Asia
7
Guinea
6
Cameroon
6
Haiti
6
Madagascar
6
Thailand
5
Central African Republic
5
Lesotho
5
Lebanon
4
Burundi
4
Botswana
4
Western Pacific Region
4
Asia
4
Moldova
4
Burkina Faso
3
Mali
3
Guinea-Bissau
3
Somalia
3
Jordan
3
Cambodia
3
Sudan
3
Benin
3
Angola
3
Sri Lanka
3
Yemen
3
Iraq
2
Turkey
2
Egypt
2
China
2
Colombia
2
Bhutan
2
Southern Africa
2
Timor Leste/ East Timor
2
Vietnam
2
Mauritius
2
Côte d’Ivoire / Ivory Coast
1
Niger
1
Germany
1
Gambia
1
Malaysia
1
Mauritania
1
Argentina
1
Ecuador
1
El Salvador
1
Libya
1
Chile
1
Paraguay
1
Venezuela
1
Poland
1
North Korea
1
Albania
1
Tajikistan
1
Romania
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
Japan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
599
Clinical Guidelines
87
Public Health
80
Key Resources
80
Women & Child Health
70
Capacity Building
24
Pharmacy & Technologies
11
Toolboxes
COVID-19
256
Rapid Response
89
HIV
83
Mental Health
57
Ebola
54
Conflict
49
TB
38
AMR
35
Planetary Health
31
Caregiver
26
Global Health Education
19
Disability
18
Refugee
16
Natural Hazards
15
NCDs
13
Polio
10
NTDs
10
Cholera
9
Zika
9
Health Financing Toolbox
9
Specific Hazards
6
Pharmacy
5
Social Ethics
3
Typhoon
1
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interventions within their context, closing the gaps in ca
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra
...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani
...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi
...
This module covers common Non-Communicable Diseases such as Hypertension, Diabetes and three common cancers (Cervical,
Breast and Oral cancer). The focus of this module is on building the knowledge and skills of the Multi-Purpose Workers (MPW) in
undertaking Population Based Screening, identifi ca
...
This status report shows how far we have come—and how much further we must go—if we hope to meet the global commitments to end AIDS in children. It offers a snapshot of global progress and permits an early assessment of the impact of the Global Alliance’s work.
On 14 August 2024, the Director-General of the World Health Organization determined that the upsurge of mpox in a growing number of countries in Africa constitutes a new public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005)
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes. This document outlines indicators across 4 domains: health system determinants, service delivery, ris
...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
Caring for burns patients from the incident scene to definitive treatment can be a complex, resource-consuming process with the potential to overwhelm health system capacity.This document provides practical guidance for building capacity and capability for burns care from clinical, human resources a
...
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame
...
From choice, a world of possibilities
This document is a guide for national authorities who are responsible for managing public health responses to COVID-19
Recognizing the extent to which the COVID-19 outbreaks affects women and men differently is hugely important. Some preliminary data suggested that more men than women are dying, potentially due to sex-based immunological differences, higher rates of cardiovascular disease for men and lifestyle choic
...
1 February 2021 to 31 January 2022
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at
...
